-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Cocrystal Pharma, Lowers Price Target to $6

Benzinga·06/20/2025 11:16:55
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price target from $7 to $6.